Med4Cast S.A. announced that it has received CHF 12,500 at par value on March 29, 2022. The transition included participation from new investor, Katalysen Ventures AB (publ) who owns 20% stake of the company as a part of the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19 SEK | -0.52% | +6.15% | +43.94% |
15/04 | Katalysen Ventures Portfolio Company Files for Bankruptcy | MT |
14/03 | Katalysen Ventures Unit Buys Germany's Smart4Diagnostics | MT |
1st Jan change | Capi. | |
---|---|---|
+43.94% | 13.41M | |
+18.18% | 3.17B | |
+31.41% | 2.06B | |
+8.43% | 1.5B | |
-8.46% | 1.23B | |
+6.27% | 671M | |
+3.80% | 631M | |
+33.25% | 578M | |
-1.12% | 498M | |
+27.48% | 476M |
- Stock Market
- Equities
- KAV Stock
- News Katalysen Ventures AB
- Med4Cast S.A. announced that it has received funding from Katalysen Ventures AB